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ABSTRACT
Objective: To examine associations between sexual
behaviour, sexual function and sexual health service
use of individuals with depression in the British
general population, to inform primary care and
specialist services.
Setting: British general population.
Participants: 15 162 men and women aged
16–74 years were interviewed for the third National
Survey of Sexual Attitudes and Lifestyles (Natsal-3),
undertaken in 2010–2012. Using age-adjusted ORs
(aAOR), relative to a comparator group reporting no
treatment or symptoms, we compared the sexual
health of those reporting treatment for depression in
the past year.
Outcome measures: Sexual risk behaviour, sexual
function, sexual satisfaction and sexual health service
use.
Results: 1331 participants reported treatment for
depression (5.2% men; 11.8% women). Relative to the
comparator group, treatment for depression was
associated with reporting 2 or more sexual partners
without condoms (men aAOR 2.07 (95% CI 1.38 to
3.10); women 2.22 (1.68 to 2.92)), and concurrent
partnerships (men 1.80 (1.18 to 2.76); women 2.06
(1.48 to 2.88)), in the past year. Those reporting
depression treatment were more likely to be dissatisfied
with their sex lives (men 2.32 (1.74 to 3.11); women
2.30 (1.89 to 2.79)), and to score in the lowest quintile
on the Natsal-sexual function measure. They were also
more likely to report a recent chlamydia test (men 1.92
(1.15 to 3.20)); women (1.27 (1.01 to 1.60)), and to
have sought help regarding their sex life from a
healthcare professional (men 2.92 (1.98 to 4.30);
women (2.36 (1.83 to 3.04)), most commonly from a
family doctor. Women only were more likely to report
attending a sexual health clinic (1.91 (1.42 to 2.58))
and use of emergency contraception (1.98 (1.23 to
3.19)). Associations were broadly similar for
individuals with depressive symptoms but not
reporting treatment.
Conclusions: Depression, measured by reported
treatment, was strongly associated with sexual risk
behaviours, reduced sexual function and increased use
of sexual health services, with many people reporting
help doing so from a family doctor. The sexual health
of depressed people needs consideration in primary
care, and mental health assessment might benefit
people attending sexual health services.
INTRODUCTION
In the UK, the estimated point prevalence of
a major depressive episode among those
aged 16–74 years is 2.6%, with less severe
depression present in 9.1% of men and
13.6% of women.1 Over 90% of adults with
Strengths and limitations of this study
▪ The major strength of this study lies in the com-
prehensive data collected on sexual behaviour,
function and health service use linked to self-
reported information on depression in a large
probability sample. The National Survey of
Sexual Attitudes and Lifestyles (Natsal-3) con-
sidered sexual health in its broadest sense
according to the WHO-endorsed definition, and
furthermore used the Natsal-SF measure, which
takes account not only of sexual difficulties, but
also the relationship context and overall levels of
sexual satisfaction.
▪ The response rate for Natsal-3 (57.7%) was
similar to other major social surveys, however,
there may be systematic biases in who agrees to
take part. To minimise this, we weighted the data
to match the age, sex and regional profile of the
British population according to the 2011 census.
Once these weights had been applied, the
Natsal-3 sample composition was generally com-
parable with the British population in terms of
marital status, ethnic group, and self-reported
general health.19–21
▪ Although the potential for reporting bias was
minimised by using computer-assisted self-
interview (CASI) and non-response weighting,
our cross-sectional data should be interpreted
with caution, and we note that causality cannot
be assumed.
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depression are managed in primary care by their family
doctor,2 and depression forms a large part of general
practice (GP) case load, presenting in up to a quarter of
GP attendees.3 4 Psychological morbidity is also common
in attendees of specialist sexual health clinics (ie, genito-
urinary medicine (GUM) clinics); one study found that
over half the patients attending a London GUM clinic
had experienced symptoms of depression, anxiety, or
both in the past month,5 but this phenomenon is not
well studied.
Depression has profound effects on quality of life,
including sexual interest and behaviour.6 Studies, primar-
ily in the USA and in adolescents, have shown associa-
tions between depression and sexual risk behaviours,7–11
and two North American studies extended these findings
to adults.12 13 Sexual dysfunction and depression fre-
quently occur together, but the nature of their associ-
ation is not well understood. Although reduced desire is
most often reported, problems with arousal, resulting in
vaginal dryness in women and erectile dysfunction in
men, and absent or delayed orgasm are also common,
and erectile dysfunction is sometimes used as a marker
for depression.14 15 Understanding the interaction
between depression and sexual function is complicated
by difficulty in determining the direction of causality,16 17
the fact that patient groups are rarely treatment naïve,
and by whether the condition or its treatment has the
largest effect, since most antidepressants have undesired
effects on sexual function.18
Few studies have investigated the overlap between
sexual and mental well-being across the life course, and
little is known about the sexual behaviour and sexual
health service use of individuals with depression in the
general population. This paper uses data from the third
National Survey of Sexual Attitudes and Lifestyles
(Natsal-3) to investigate the nature and strength of asso-
ciations between depression and sexual behaviour, sexual
function and sexual health service use in a representative
sample of the British population aged 16–74 years.
METHODS
Participants and procedures
Full details of the methods of Natsal-3 have been
reported elsewhere.19–21 Briefly, households across
Britain were selected using stratified probability sam-
pling from which one eligible individual was selected at
random and invited to participate. Altogether, 15 162
men and women aged 16–74 years were interviewed
between September 2010 and August 2012. The overall
response rate was 57.7%, and the cooperation rate was
65.8% (defined as the number of interviews completed
from eligible addresses for which contact was
made).19 22 An anonymised data set has been deposited
with the UK Data Service, persistent identified: 10.5255/
UKDA-SN-7799–1, and the complete questionnaire and
technical report are available on the Natsal website
(http://www.natsal.ac.uk/home.aspx).
Participants were interviewed in their own homes by
professional interviewers using computer-assisted per-
sonal interview. Participants were asked whether they
had been diagnosed or treated for a range of chronic
health conditions, listed on showcards,23 from which
participants selected those they had experienced. In this
way, a card was used to ask participants, ‘Are you cur-
rently taking any type of medicine prescribed by a
doctor for depression?’. Participants subsequently com-
pleted a computer-assisted self-interview (CASI), which
included a validated patient health questionnaire
(PHQ-2), comprising two screening questions (‘During
the past 2 weeks have you often been bothered by
feeling down, depressed, or hopeless?’, and ‘During the
past 2 weeks have you often been bothered by little inter-
est or pleasure in doing things?’) to assess depressive
symptoms in the past 2 weeks (each scored 0–3).24
Participants were deemed to have depressive symptoms
if they had a total score of three or more, a cut-off that
has been previously validated.25
We identified a number of permutations in the groups
that might be selected for analysis. To focus the analysis
for a clinical practice audience, we selected three mutu-
ally exclusive groups of participants for comparison who
might be readily defined in a clinical setting (figure 1),
(1) individuals reporting treatment for depression, here-
after referred to as ‘treated for depression’, who were
either being currently treated or had stopped treatment
in the past year; (2) individuals reporting depressive
symptoms within the past 2 weeks but not reporting
treatment for depression in the past year, referred to as
having ‘depressive symptoms’ and (3) a comparator
group not treated for depression and without depressive
Strengths and limitations of this study
▪ In prioritising sexual health data collection, we relied on self-
reporting of treatment for depression to an interviewer using
computer-assisted personal interview (rather than objective
clinical diagnosis or longer diagnostic tools), to identify a clin-
ically meaningful group that would be relevant to family
doctors and sexual health specialists. Although the prevalence
and distribution of depression according to age, health and
other factors matched data from other studies and data
sources, we are not able to distinguish between pharmaco-
logical and psychological treatments for depression, the stage
of treatment, or the extent to which treatment might be attenu-
ating symptoms. We included a second measure of depression
using the PHQ-2 screening tool, and found similar patterns of
associations with a range of dependent sexual health variables
for the group screening positive for recent depressive symp-
toms. This observation serves both to validate our findings
and is suggestive of a population group with depressive symp-
toms and poor sexual health who might not be accessing, or
adequately served by, healthcare services.
▪ The study is restricted to those reporting sexual experience
who answered the Natsal-3 CASI, which corresponds to more
than 95% of the British population.
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symptoms. We included only sexually experienced parti-
cipants, defined as those who reported having had one
or more sexual partner by the time of their interview,
because those reporting no previous sexual experience
did not complete the CASI. We excluded from the ana-
lysis those reporting treatment from a healthcare profes-
sional in the past year for ‘any other mental health
condition’ (12 men and 16 women).
The CASI included a range of other questions, includ-
ing those asking about having sex without condoms,
paying for sex, concurrent sexual partnerships, self-
appraisal of sex life and sexual health service use,
including reported clinic attendance, use of emergency
contraception, and testing for sexually transmitted infec-
tions (STI).20 Our assessment of sexual function used
the Natsal-SF,26 a validated measure comprising compo-
nents on problems with sexual response, sexual function
in a relationship context and self-appraisal of sex life.
Wherever possible, the timeframes used in the analysis
were those closest to the time frame for reporting treat-
ment for depression (past year) or depressive symptoms
(past 2 weeks).
Statistical analyses
Analyses were carried out using the complex survey
function of Stata V.13.1 (StataCorp LP, College Station,
Texas, USA), accounting for the weighting, clustering
and stratification of the Natsal-3 data. Survey weights
were applied to adjust for unequal probability of selec-
tion and non-response to ensure the sample data were
broadly representative of the British general population,
according to the 2011 census, in terms of gender, age
group and Government Office Region.20 21
We estimated the prevalence with 95% CIs of report-
ing treatment for depression and depressive symptoms,
by demographic and health factors. Our approach to
multivariable analysis was guided by consideration of the
obvious confounders, and we have been careful not to
‘over-adjust’. We feel that only age can be said to have
an ‘obvious’ association with the behavioural outcomes
that would confound the associations presented in this
paper. We therefore used binary and ordinal logistic
regression models to calculate age-adjusted ORs
(aAORs) to examine associations between treatment for
depression, or depressive symptoms in the absence of
treatment, relative to the comparator group (those not
treated for depression and without depressive symp-
toms), and (1) risky sexual behaviours, (2) sexual func-
tion and (3) sexual health service use.
RESULTS
Prevalence of depression
Among 13 507 sexually experienced Natsal-3 participants
aged 16–74 years (5533 men and 7974 women), the esti-
mated prevalence of having received ‘treatment for
depression’ in the past year was 5.2% (95% CI 4.6% to
5.9%) in men and 11.8% (11.0% to 12.7%) in women
(tables 1 and 2; figure 1). A further 6.7% (6.0% to
7.5%) of men and 6.4% (5.8% to 7.1%) of women had
‘depressive symptoms’ in the past 2 weeks but did not
report treatment in the past year, while 1.8% (1.5% to
Figure 1 Proportional Venn diagrams showing the prevalence of ‘treatment for depression’ (i), and ‘depressive symptoms’ (ii)
among men and women reporting one sexual partner, ever.
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2.3%) of men and 3.9% (3.5% to 4.5%) of women
reported treatment for depression and had depressive
symptoms. In both men and women, treatment for
depression was highest among those aged 35–64 years,
whereas depressive symptoms were most common in
those aged 16–24 years.
Treatment for depression
After adjusting for age, treatment for depression was
more common among men and women reporting a pre-
vious live-in partnership but currently single, and those
currently in a non-cohabiting steady relationship (tables
1 and 2). There were 16.1% of men and 21.8% of
women who reported ending a cohabiting relationship
in the past year who had received treatment for depres-
sion in the same period, compared with 5.2% of men
and 11.8% of women in the comparator group without
depression (aAORs 4.47 (2.93 to 6.83) for men and 2.28
(1.76 to 2.96) for women). Treatment for depression was
also more likely to be reported by those with lower aca-
demic attainment, those living in more deprived areas,
as measured by area-level deprivation, and by men self-
identifying as gay or bisexual, and by bisexual women.
Nearly one-third of men and nearly one-fifth of
women self-reporting bad or very bad general health
status reported treatment for depression, and the associ-
ation remained strong after adjusting for age (aAORs
12.07 (8.08 to 18.06) for men and 7.41 (5.48 to 10.01)
for women) (tables 1 and 2). Treatment for depression
was also more likely among men and women who
smoked and those who had taken recreational drugs in
the past year. The association with binge drinking was
less clear; for women only, treatment for depression was
associated with reporting weekly consumption of six or
more units of alcohol on any one occasion.
Sexual behaviour and STI risk
Men and women treated for depression reported fewer
occasions of sexual activity in the past 4 weeks than the
comparator group (table 3). After adjusting for age,
reporting treatment for depression remained strongly
associated with sexual behaviours that are markers for
STI transmission. Treatment for depression was asso-
ciated with reporting sex without condoms with two or
more partners in the past year (aAOR 2.07 (1.38 to
3.10) in men and aAOR 2.22 (1.68 to 2.92) in women),
and a same-sex partner in the past 5 years (aAOR 2.70
(1.57 to 4.62) in men and aAOR 2.02 (1.44 to 2.83) in
women). In women, treatment for depression was also
associated with partnership concurrency in the past
5 years (aAOR 2.01 (1.59 to 2.55)), the perception that a
partner had had sex with someone else in the past
5 years (aAOR 1.55 (1.28 to 1.86)), and a higher self-
perceived risk of STIs (aAOR 1.99 (1.26 to 3.15)).
Sexual function
Among those with at least one sexual partner in the past
year (5054 men and 7332 women), individuals reporting
treatment for depression were much more likely, after
adjusting for age, than those without any depression to
have ‘low sexual function’ as measured using the
Natsal-SF score: for men treated for depression, the
aAOR was 2.55 (1.85 to 3.52) and in women was 2.64
(2.16 to 3.23).
Among those treated for depression, 29.5% of men
and 22.4% of all women reported being dissatisfied with
their sex life, compared to 15.1% of men and 11.2% of
women without depression, and the association remained
after adjusting for age (table 4). There were strong asso-
ciations between depression and other specific indicators
of low sexual function, and the adjusted ORs were of
similar magnitude when comparing men and women
across the different variables. We found similar associa-
tions between depression and lacking interest in sex, and
having trouble reaching orgasm. In all cases, the associa-
tions were not affected by adjusting for age (data shown)
or relationship status (data not shown).
There were strong associations between treatment for
depression and reporting that a health condition had
affected sexual activity, although we do not know
whether the condition was depression. Similarly, 36.5%
of men and 24.5% of women who reported taking medi-
cations that had limited their sexual activity also
reported treatment for depression (aAORs 10.28 (7.22
to 14.63) for men and 8.15 (6.44 to 10.31) for women)
(table 4). Those treated for depression were more likely
to report taking drugs to assist their sexual performance
(aAORs 1.77 (1.12 to 2.81) for men and 2.62 (1.39 to
4.93) for women).
Use of sexual health services
For men, although there was no association between
reporting treatment for depression and sexual health
clinic attendance in the past year, those treated for
depression were more likely to report a recent chlamydia
test (aAOR 1.92 (1.15 to 3.20), and to have sought help
regarding their sex life in the past year from a healthcare
professional (aAOR 2.92 (1.98 to 4.30) (table 5). The
source of professional help was their GP/family doctor
for 70% of these men, a psychiatrist/psychologist for
20%, and another healthcare provider for 10%.
Women treated for depression were more likely to
report attending a sexual health clinic (aAORs 1.91
(1.42 to 2.58)), having a recent chlamydia test (aAOR
1.27 (1.01 to 1.60)), and use of emergency contracep-
tion in the past year (aAOR 1.98 (1.23 to 3.19), and
were also more likely to have sought professional help
regarding their sex life (aAOR 2.36 (1.83 to 3.04)).
GPs/family doctors were the source of sexual advice in
70% of these women, and a sexual health clinic, psych-
iatrist/psychologist or relationship counsellor were each
reported by 10%.
Depressive symptoms
In a second analysis, using the same statistical approach,
we investigated the sexual health of participants
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Table 1 Variations in the prevalence of reporting treatment for depression and depressive symptoms by key demographic and health characteristics, men
Men
Not treated and without
depressive symptoms Treatment within the past year Depressive symptoms (without treatment)
Unweighted,
weighted
denominatorPer cent CI (%) Per cent CI (%) aAOR* Per cent CI (%) aAOR†
Overall
88.1 (87.1 to 89.0) 5.2 (4.6 to 5.9) – 6.7 (6.0 to 7.5) – 5533, 6789
Age group
16–24 88.1 (86.1 to 89.9) 2.6 (1.8 to 3.7) 1.00 9.3 (7.7 to 11.1) 1.00 1346, 984
25–34 88.5 (86.5 to 90.2) 4.4 (3.4 to 5.6) 1.66 (1.06 to 2.58) 7.1 (5.7 to 8.9) 0.77 (0.56 to 1.05) 1398, 1256
35–44 87.4 (84.8 to 89.7) 6.8 (5.3 to 8.8) 2.61 (1.65 to 4.15) 5.8 (4.2 to 7.8) 0.63 (0.43 to 0.92) 762, 1357
45–54 88.2 (85.7 to 90.3) 6.2 (4.7 to 8.2) 2.37 (1.47 to 3.80) 5.5 (4.1 to 7.4) 0.60 (0.41 to 0.87) 728, 1316
55–64 85.3 (82.2 to 87.9) 6.9 (5.2 to 9.1) 2.73 (1.70 to 4.37) 7.8 (5.8 to 10.4) 0.87 (0.60 to 1.26) 698, 1097
65–74 92.4 (89.9 to 94.3) 2.8 (1.8 to 4.3) 1.01 (0.55 to 1.84) 4.8 (3.2 to 7.0) 0.49 (0.31 to 0.78) 601, 778
Relationship status
Living with a partner 91.0 (89.8 to 92.0) 3.6 (3.0 to 4.4) 1.00 5.4 (4.6 to 6.4) 1.00 2912, 4628
Steady relationship (not
cohabiting)
86.7 (84.0 to 89.0) 6.3 (4.6 to 8.7) 2.05 (1.35 to 3.09) 7.0 (5.3 to 9.0) 1.26 (0.89 to 1.79) 933, 748
Previously in a live-in
partnership
73.8 (70.3 to 77.1) 15.5 (12.7 to 18.6) 5.21 (3.82 to 7.11) 10.7 (8.6 to 13.2) 2.46 (1.81 to 3.34) 754, 674
Not in a steady
relationship (never
cohabited)
85.0 (82.2 to 87.5) 4.5 (3.2 to 6.3) 1.54 (0.98 to 2.41) 10.5 (8.4 to 12.9) 1.90 (1.34 to 2.69) 894, 702
Ended a cohabiting relationship, past year
No 88.8 (87.8 to 89.7) 4.7 (4.1 to 5.4) 1.00 6.5 (5.8 to 7.3) 1.00 5094, 6398
Yes 72.0 (65.6 to 77.7) 16.1 (11.4 to 22.1) 4.47 (2.93 to 6.83) 11.9 (8.2 to 17.0) 2.14 (1.38 to 3.31) 277, 237
Sexual identity
Heterosexual/straight 88.4 (87.4 to 89.3) 5.0 (4.4 to 5.6) 1.00 6.6 (5.9 to 7.4) 1.00 5349, 6599
Gay 81.6 (71.2 to 88.8) 14.7 (8.5 to 24.2) 3.32 (1.75 to 6.30) 3.8 (1.3 to 10.5) 0.60 (0.20 to 1.79) 106, 102
Bisexual 70.7 (56.1 to 82.1) 10.8 (5.2 to 21.0) 2.74 (1.20 to 6.27) 18.5 (9.5 to 33.0) 3.52 (1.56 to 7.94) 61, 71
Other NA NA NA NA NA NA NA NA 13, 11
Academic qualifications‡
No academic
qualifications
83.9 (81.4 to 86.1) 7.4 (6.0 to 9.2) 1.00 8.7 (7.0 to 10.8) 1.00 1153, 1509
Academic qualifications
typically gained at age
16 years
87.9 (86.1 to 89.4) 5.7 (4.6 to 6.9) 0.72 (0.51 to 1.03) 6.5 (5.3 to 7.9) 0.61 (0.43 to 0.85) 1921, 2322
Studying for/attained
further academic
qualifications
90.2 (88.8 to 91.5) 4.0 (3.2 to 4.9) 0.50 (0.34 to 0.72) 5.8 (4.8 to 7.0) 0.51 (0.37 to 0.72) 2851, 3361
Deprivation quintile
1 (least deprived) 91.4 (89.4 to 93.0) 3.2 (2.3 to 4.5) 1.00 5.4 (4.2 to 6.9) 1.00 1096, 1428
2 90.9 (88.8 to 92.7) 3.9 (2.7 to 5.4) 1.21 (0.73 to 2.02) 5.2 (3.9 to 7.0) 0.97 (0.64 to 1.47) 1109, 1459
Continued
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Table 1 Continued
Men
Not treated and without
depressive symptoms Treatment within the past year Depressive symptoms (without treatment)
Unweighted,
weighted
denominatorPer cent CI (%) Per cent CI (%) aAOR* Per cent CI (%) aAOR†
3 89.1 (86.8 to 91.1) 5.0 (3.8 to 6.6) 1.65 (1.04 to 2.61) 5.8 (4.4 to 7.7) 1.10 (0.73 to 1.65) 1081, 1320
4 85.9 (83.3 to 88.1) 6.2 (4.8 to 7.9) 2.16 (1.38 to 3.38) 7.9 (6.3 to 10.0) 1.53 (1.04 to 2.25) 1098, 1337
5 (most deprived) 82.3 (79.7 to 84.7) 8.1 (6.6 to 10.0) 2.99 (1.95 to 4.58) 9.5 (7.7 to 11.7) 1.91 (1.32 to 2.76) 1149, 1245
Self-reported health
Fair/good/very good 89.5 (88.5 to 90.3) 4.3 (3.7 to 5.0) 1.00 6.2 (5.6 to 7.0) 1.00 5338, 6545
Bad/very bad 52.0 (43.9 to 59.9) 29.4 (23.1 to 36.7) 12.07 (8.07 to 18.06) 18.6 (13.0 to 25.9) 6.19 (3.85 to 9.95) 193, 241
Drink >6/8 units on one occasion—weekly
No 88.2 (87.0 to 89.3) 5.2 (4.5 to 6.0) 1.00 6.6 (5.7 to 7.5) 1.00 3969, 4997
Yes 88.6 (86.6 to 90.4) 5.0 (3.8 to 6.4) 0.97 (0.71 to 1.33) 6.4 (5.1 to 8.0) 0.94 (0.71 to 1.24) 1209, 1371
Taken recreational drugs, past year
No 89.4 (88.4 to 90.3) 4.7 (4.1 to 5.4) 1.00 5.9 (5.2 to 6.7) 1.00 4426, 5746
Yes 80.8 (77.7 to 83.5) 8.2 (6.5 to 10.4) 2.47 (1.76 to 3.47) 11.0 (8.9 to 13.5) 2.02 (1.50 to 2.71) 1098, 1031
Current cigarette smoker
No 89.9 (88.8 to 91.0) 4.0 (3.4 to 4.8) 1.00 6.0 (5.2 to 7.0) 1.00 3886, 4998
Yes 83.0 (81.0 to 84.9) 8.4 (7.1 to 10.0) 2.40 (1.83 to 3.14) 8.5 (7.2 to 10.1) 1.48 (1.16 to 1.88) 1647, 1791
All participants who have had at least one opposite-sex or same-sex partner, ever.
*OR for the outcome of reporting treatment for depression compared to not treated for depression—screened negative.
†OR for the outcome of reporting screened positive for depression compared to not treated for depression—screened negative.
‡Participants aged 17+ years.
aAOR, age-adjusted OR; NA, non-applicable due to too few participants.
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Table 2 Variations in the prevalence of reporting treatment for depression and depressive symptoms by key demographic and health characteristics, women
Women
Not treated and without
depressive symptoms Treatment within the past year Depressive symptoms (without treatment)
Unweighted,
weighted
denominatorPer cent CI (%) Per cent CI (%) aAOR* Per cent CI (%) aAOR†
Overall
81.7 (80.7 to 82.7) 11.8 (11.0 to 12.7) – 6.4 (5.8 to 7.1) – 7974, 6995
Age group
16–24 80.8 (78.6 to 82.8) 9.2 (7.7 to 10.8) 1.00 10.1 (8.6 to 11.7) 1.00 1688, 936
25–34 82.5 (80.8 to 84.1) 11.7 (10.4 to 13.1) 1.25 (1.00 to 1.57) 5.8 (4.8 to 6.9) 0.56 (0.43 to 0.73) 2315, 1278
35–44 80.5 (77.9 to 82.8) 13.6 (11.7 to 15.8) 1.49 (1.16 to 1.93) 5.9 (4.6 to 7.6) 0.59 (0.43 to 0.82) 1153, 1385
45–54 78.7 (75.8 to 81.4) 14.8 (12.6 to 17.4) 1.66 (1.28 to 2.17) 6.4 (5.0 to 8.4) 0.66 (0.48 to 0.91) 1044, 1364
55–64 83.0 (80.4 to 85.4) 12.0 (10.0 to 14.3) 1.28 (0.98 to 1.67) 5.0 (3.7 to 6.7) 0.48 (0.33 to 0.70) 967, 1167
65–74 86.7 (83.9 to 89.1) 7.2 (5.5 to 9.4) 0.73 (0.51 to 1.04) 6.1 (4.5 to 8.2) 0.57 (0.40 to 0.80) 807, 865
Relationship status
Living with a partner 84.3 (83.1 to 85.5) 10.2 (9.2 to 11.2) 1.00 5.5 (4.7 to 6.3) 1.00 4306, 4647
Steady relationship (not
cohabiting)
79.6 (77.0 to 82.1) 13.0 (11.0 to 15.3) 1.26 (1.00 to 1.59) 7.3 (5.9 to 9.2) 1.26 (0.92 to 1.71) 1341, 779
Previously in a live-in
partnership
73.6 (71.0 to 76.0) 18.4 (16.4 to 20.7) 2.13 (1.77 to 2.57) 8.0 (6.6 to 9.6) 1.75 (1.34 to 2.28) 1558, 1108
Not in a steady
relationship (never
cohabited)
78.6 (75.0 to 81.8) 10.4 (8.1 to 13.2) 1.00 (0.73 to 1.37) 11.0 (8.8 to 13.7) 1.84 (1.35 to 2.50) 719, 426
Ended a cohabiting relationship, past year
No 82.3 (81.3to 83.3) 11.5 (10.6to 12.4) 1.00 6.2 (5.6 to 6.9) 1.00 7219, 6562
Yes 68.3 (63.4 to 72.8) 21.8 (18.0 to 26.2) 2.28 (1.76 to 2.96) 9.9 (7.0to 13.8) 1.77 (1.18 to 2.67) 484, 256
Sexual identity
Heterosexual/straight 82.1 (81.0 to 83.0) 11.6 (10.8 to 12.5) 1.00 6.3 (5.7 to 7.0) 1.00 7731, 6811
Gay 72.7 (61.0 to 82.0) 16.1 (9.1 to 27.1) 1.56 (0.80 to 3.05) 11.1 (5.6 to 20.9) 1.91 (0.88 to 4.12) 85, 70
Bisexual 68.7 (58.9 to 77.1) 24.3 (16.6 to 34.1) 2.46 (1.50 to 4.04) 7.0 (4.0 to 11.8) 1.15 (0.63 to 2.12) 134, 90
Other NA NA NA NA NA NA NA NA 16, 15
Academic qualifications‡
No academic
qualifications
77.1 (74.6 to 79.4) 14.9 (13.0 to 17.0) 1.00 8.0 (6.6 to 9.8) 1.00 1562, 1531
Academic qualifications
typically gained at age
16 years
79.8 (78.0 to 81.5) 14.0 (12.6 to 15.6) 0.81 (0.66 to 1.01) 6.2 (5.2 to 7.3) 0.61 (0.45 to 0.83) 2851, 2509
Studying for/attained
further academic
qualifications
85.4 (84.0 to 86.7) 9.2 (8.1 to 10.5) 0.47 (0.37 to 0.60) 5.4 (4.6 to 6.3) 0.45 (0.33 to 0.62) 3957, 3261
Deprivation quintile
1 (least deprived) 86.4 (84.4 to 88.1) 8.9 (7.4 to 10.6) 1.00 4.7 (3.7 to 6.0) 1.00 1485, 1442
2 86.5 (84.5 to 88.3) 9.2 (7.7 to 10.9) 1.03 (0.78 to 1.36) 4.3 (3.3 to 5.6) 0.91 (0.63 to 1.32) 1564, 1456
Continued
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Table 2 Continued
Women
Not treated and without
depressive symptoms Treatment within the past year Depressive symptoms (without treatment)
Unweighted,
weighted
denominatorPer cent CI (%) Per cent CI (%) aAOR* Per cent CI (%) aAOR†
3 83.6 (81.3 to 85.6) 10.1 (8.6 to 11.9) 1.18 (0.90 to 1.55) 6.3 (4.9 to 8.0) 1.34 (0.94 to 1.93) 1561, 1373
4 77.7 (75.2 to 80.0) 14.3 (12.3 to 16.5) 1.79 (1.37 to 2.33) 8.0 (6.6 to 9.7) 1.83 (1.31 to 2.55) 1650, 1389
5 (most deprived) 73.9 (71.4 to 76.2 17.2 (15.2 to 19.3) 2.27 (1.77 to 2.90) 8.9 (7.5 to 10.6) 2.13 (1.53 to 2.95) 1714, 1336
Self-reported health
Fair/good/very good 83.4 (82.4 to 84.4) 10.6 (9.8 to 11.4) 1.00 6.0 (5.4 to 6.6) 1.00 7666, 6689
Bad/very bad 45.0 (38.6 to 51.7 39.3 (33.2 to 45.8) 7.41 (5.48 to 10.01) 15.6 (11.5 to 21.0) 5.89 (3.89 to 8.92) 308, 305
Drink >6/8 units on one occasion—weekly
No 82.5 (81.4 to 83.5) 11.3 (10.4 to 12.2) 1.00 6.3 (5.6 to 7.0) 1.00 6179, 5485
Yes 79.7 (76.3 to 82.7) 14.6 (12.0 to 17.6) 1.33 (1.05 to 1.70) 5.7 (4.1 to 7.9) 0.91 (0.62 to 1.32) 930, 766
Taken recreational drugs, past year
No 82.3 (81.3 to 83.3) 11.3 (10.5 to 12.2) 1.00 6.3 (5.7 to 7.0) 1.00 7219, 6508
Yes 73.8 (69.7 to 77.4) 18.4 (15.0 to 22.3) 1.83 (1.39 to 2.41) 7.8 (6.1to 10.1) 1.20 (0.88 to 1.62) 738, 472
Current cigarette smoker
No 84.0 (82.9 to 85.0) 10.0 (9.1 to 10.9) 1.00 6.0 (5.3 to 6.8) 1.00 5759, 5331
Yes 74.6 (72.4 to 76.6) 17.8 (16.0 to 19.7) 2.01 (1.71 to 2.36) 7.7 (6.5 to 9.0) 1.38 (1.11 to 1.72) 2215, 1664
All participants who have had at least one opposite-sex or same-sex partner, ever.
*OR for the outcome of reporting treatment for depression compared to not treated for depression—screened negative.
†OR for the outcome of reporting screened positive for depression compared to not treated for depression—screened negative.
‡Participants aged 17+ years.
aAOR, age-adjusted OR; NA, non-applicable due to too few participants.
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reporting depressive symptoms in the past 2 weeks, but
not treatment in the previous year. Compared to those
reporting treatment for depression, the overall patterns
of associations were similar for individuals with depres-
sive symptoms, although the strength of associations was
generally weaker, except for sexual function, where the
associations were of a similar magnitude (see online sup-
plementary appendix tables 1–3). Some differences were
noted for men reporting depressive symptoms; for
example, we observed significant associations with
reporting of current partnerships, with the perception
that a partner had had sex with someone else in the past
5 years, and with a higher self-perceived risk of STIs;
associations that were not significant for men reporting
treatment for depression. On the contrary, there were
not associations for health service use for men, and only
Table 3 Sexual behaviour and STI risk in those reporting treatment for depression, by gender
Men Women
Not treated and without
depressive symptoms
Treatment within
the past year
Not treated and without
depressive symptoms
Treatment within
the past year
Unweighted, weighted
denominator
4809, 5981 319, 353 6413, 5718 1012, 828
2+ heterosexual/same-sex occasions of sexual intercourse, past 4 weeks*
Per cent 68.7 55.9 66.1 57.7
OR (95% CI) 1.00 0.58 (0.42 to 0.79) 1.00 0.70 (0.58 to 0.85)
aAOR (95% CI) 1.00 0.58 (0.43 to 0.80) 1.00 0.68 (0.56 to 0.82)
2+ heterosexual partners, past year
Per cent 15.1 18.0 8.7 13.4
OR (95% CI) 1.00 1.24 (0.90 to 1.71) 1.00 1.63 (1.32 to 2.01)
aAOR (95% CI) 1.00 1.48 (1.05 to 2.09) 1.00 1.90 (1.52 to 2.38)
Same-sex partner, past 5 years
Per cent 2.5 6.3 2.8 5.4
OR (95% CI) 1.00 2.59 (1.52 to 4.41) 1.00 1.94 (1.39 to 2.70)
aAOR (95% CI) 1.00 2.70 (1.57 to 4.62) 1.00 2.02 (1.44 to 2.83)
2+ heterosexual/same-sex partners without using a condom, past year
Per cent 7.4 12.2 4.4 8.0
OR (95% CI) 1.00 1.74 (1.18 to 2.57) 1.00 1.90 (1.46 to 2.48)
aAOR (95% CI) 1.00 2.07 (1.38 to 3.10) 1.00 2.22 (1.68 to 2.92)
Paid for heterosexual/same sex, past year
Per cent 1.1 2.2 0.1 0.0
OR (95% CI) 1.00 2.11 (0.76 to 5.89) NA NA
aAOR (95% CI) 1.00 2.11 (0.76 to 5.92) NA NA
Concurrent partnerships, past 5 years
Per cent 15.0 16.9 7.1 12.0
OR (95% CI) 1.00 1.15 (0.83 to 1.60) 1.00 1.79 (1.43 to 2.25)
aAOR (95% CI) 1.00 1.27 (0.90 to 1.78) 1.00 2.01 (1.59 to 2.55)
Know/ perceive their most recent partner had sex with someone else, past 5 years†
Per cent 22.8 28.5 22.2 30.6
OR (95% CI) 1.00 1.35 (0.95 to 1.91) 1.00 1.55 (1.28 to 1.87)
aAOR (95% CI) 1.00 1.36 (0.95 to 1.93) 1.00 1.55 (1.28 to 1.87)
Diagnosed with a STI, past year
Per cent 0.9 1.1 0.8 1.1
OR (95% CI) 1.00 1.34 (0.44 to 4.07) 1.00 1.33 (0.72 to 2.44)
aAOR (95% CI) 1.00 1.80 (0.59 to 5.54) 1.00 1.58 (0.86 to 2.90)
Self-perceived risk of STI: Quite a lot or greater
Per cent 3.4 4.1 2.1 3.9
OR (95% CI) 1.00 1.20 (0.69 to 2.09) 1.00 1.93 (1.22 to 3.03)
aAOR (95% CI) 1.00 1.34 (0.77 to 2.35) 1.00 1.99 (1.26 to 3.15)
All participants who have had at least one opposite-sex or same-sex partner, ever (denominators may vary across variables due to item
non-response).
Bold typeface highlights results where the confidence intervals exclude 1.0.
*Denominator restricted to those reporting at least one heterosexual or same-sex partner in the last year (men: not treated and without
depressive symptoms—48 095 981; treated for depression—319 353; women: not treated and without depressive symptoms—64 135 718;
treated for depression—1 012 828).
†Denominator restricted to those reporting a sexual partnership in the past 5 years (Men: Not treated and without depressive symptoms –
3955, 3912; Treated for depression – 241, 197 | Women: Not treated and without depressive symptoms – 5273, 3657; Treated for depression
– 824, 465).
aAOR, age-adjusted OR; STI, sexually transmitted infections; NA, non-applicable due to too few participants.
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an association with seeking professional help for women
with depressive symptoms.
DISCUSSION
Statement of principal findings
This study investigated the sexual health of people with
a history of treatment for depression or depressive symp-
toms in a representative sample of the sexually experi-
enced British general population aged 16–74 years.
Individuals treated for depression, or with depressive
symptoms, were more likely to report a range of sexual
health difficulties. Those treated for depression were
more likely to report behaviours linked to STI acquisi-
tion and/or transmission27 and depression was also
strongly associated with low sexual function among men
and women. For example, around two-thirds of those
treated for depression reported problems with their sex
lives, but only around 15% had sought professional help
(and in most cases this was their GP/family doctor). Age
adjustment made little difference to these findings, sug-
gesting that these problems are experienced at all ages.
Women treated for depression, but not men, were more
likely to report accessing sexual health clinics, suggesting
Table 4 Sexual function of those reporting treatment for depression, by gender
Men Women
Not treated and without
depressive symptoms
Treatment within
the past year
Not treated and without
depressive symptoms
Treatment within
the past year
Unweighted, weighted
denominator
4750, 5914 314, 348 6334, 5650 998, 814
Lowest quintile of sexual function (ref)
Per cent 17.3 34.8 16.2 33.1
OR (95% CI) 1.00 2.55 (1.85 to 3.51) 1.00 2.55 (2.09 to 3.12)
aAOR (95% CI) 1.00 2.55 (1.85 to 3.52) 1.00 2.64 (2.16 to 3.23)
Components of the Natsal-SF score* (ref)
Have experienced problems, for 3+ months, past year
Per cent 39.3 62.1 46.7 68.5
OR (95% CI) 1.00 2.54 (1.86 to 3.45) 1.00 2.48 (2.06 to 3.00)
aAOR (95% CI) 1.00 2.53 (1.85 to 3.45) 1.00 2.52 (2.09 to 3.04)
Lacked interest in having sex, for 3+ months, past year
Per cent 13.0 29.0 30.0 50.9
OR (95% CI) 1.00 2.74 (1.95 to 3.87) 1.00 2.42 (2.02 to 2.91)
aAOR (95% CI) 1.00 2.74 (1.94 to 3.86) 1.00 2.46 (2.05 to 2.96)
No orgasm or took a long time to reach orgasm despite arousal, for3+ months, past year
Per cent 8.2 20.0 14.2 24.9
OR (95% CI) 1.00 2.80 (1.91 to 4.12) 1.00 2.00 (1.62 to 2.48)
aAOR (95% CI) 1.00 2.80 (1.90 to 4.12) 1.00 2.00 (1.61 to 2.48)
Trouble achieving/maintaining erections, for 3+ months, past year
Per cent 12.2 20.0
OR (95% CI) 1.00 1.80 (1.22 to 2.66)
aAOR (95% CI) 1.00 1.86 (1.25 to 2.78)
Disagree/ disagree strongly to the statement: “I feel satisfied with my sex life"
Per cent 15.1 29.5 11.2 22.4
OR (95% CI) 1.00 2.35 (1.76 to 3.14) 1.00 2.28 (1.88 to 2.77)
aAOR (95% CI) 1.00 2.32 (1.74 to 3.11) 1.00 2.30 (1.89 to 2.79)
Perceive a health condition/disability has affected sexual activity/enjoyment, past year
Per cent 13.5 45.7 12.8 36.7
OR (95% CI) 1.00 5.40 (4.10 to 7.09) 1.00 3.94 (3.31 to 4.70)
aAOR (95% CI) 1.00 5.74 (4.29 to 7.68) 1.00 3.96 (3.32 to 4.72)
Perceive medications taken have limited sexual activity/enjoyment, past year
Per cent 6.2 36.5 3.8 24.5
OR (95% CI) 1.00 8.69 (6.39 to 11.82) 1.00 8.15 (6.44 to 10.31)
aAOR (95% CI) 1.00 10.28 (7.22 to 14.63) 1.00 8.15 (6.44 to 10.31)
Taken any medicine/pills to assist sexual performance, past year
Per cent 6.2 10.6 0.7 1.7
OR (95% CI) 1.00 1.80 (1.16 to 2.80) 1.00 2.54 (1.33 to 4.88)
aAOR (95% CI) 1.00 1.77 (1.12 to 2.81) 1.00 2.62 (1.39 to 4.93)
All participants who have had at least one opposite-sex or same-sex partner, ever (denominators may vary across variables due to item
non-response).
Bold typeface highlights results where the confidence intervals exclude 1.0.
*All participants who have had at least one opposite-sex or same-sex partner, past year.
aAOR, age-adjusted ORo; Natsal, National Survey of Sexual Attitudes and Lifestyles.
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that depressed men in particular might be inadequately
served by sexual health services.
We observed similar associations for a second group in
the population, those with current depressive symptoms
but no history of being treated for depression in the
past year, for whom there was also evidence of being at
greater risk of STIs, and having worse sexual function.
This group is likely to include individuals with unmet
mental health needs, who might be readily identifiable
within a clinic population using the PHQ-2 screening
tool. It was noticeable that this group was not more
likely than those without reported symptoms or treated
depression to use health services, suggesting coexiting
unmet needs of mental health and sexual health.
These data provide valuable information to GPs, as
well as to sexual health specialists, which may be used to
improve the sexual health of patients with depression.
Comparison with other studies
Our study is unique in taking a broad-based approach to
understanding the relationship between depression and
sexual health at a general population level across the life
course, and considering three key components of sexual
health in people with depression: behaviour, function
and health service use. This study considerably extends
our previous work, where we showed that poor health,
including depression, is independently associated with
reduced sexual well-being at all ages in Britain.23 28
Other studies have reported on behaviour and function
in isolation, and not considered service use. There is
good evidence to suggest that depression is associated
with increased sexual risk-taking in adolescent popula-
tions in North America. For example, the US National
Longitudinal Adolescent Health Study found that
depression was associated with reporting multiple part-
ners, but was not associated with condom use (key to
STI transmission),9 but there is a lack of consensus
about the direction of association.29 30 Two studies are
noteworthy in adult populations, again from North
America. Pratt et al, found associations in US women
aged 20–59 years between depressive symptoms (scored
using the nine-question PHQ-9) and age at first sex,
numbers of sexual partners in the past year, and infec-
tion with Herpes Simplex Virus-2, but there were no
associations in men.12 Chen et al,13 used a 27-question
approach to determine major depressive episodes in the
past 12 months in a sample of Canadians aged 15–
49 years, and found an association between a history of
STIs and depressive symptoms in women and men
younger than 35 years. By contrast, our study focuses on
a group reporting clinical treatment, and found associa-
tions in both men and women across the life course.
Table 5 Sexual health service use of those reporting treatment in the past year, by gender
Men Women
Not treated and without
depressive symptoms
Treatment within
the past year
Not treated and without
depressive symptoms
Treatment within
the past year
Unweighted, weighted
denominator
4809, 5981 319, 353 6413, 5718 1012, 828
Attended a sexual health (GUM) clinic, past year
Per cent 4.2 2.8 4.4 6.5
aAOR (95% CI) 1.00 0.94 (0.51 to 1.73) 1.00 1.91 (1.42 to 2.58)
AOR* (95% CI) 1.00 0.64 (0.33 to 1.25) 1.00 1.60 (1.15 to 2.24)
Had a chlamydia test, past year†
Per cent 15.6 18.0 25.1 25.7
aAOR (95% CI) 1.00 1.92 (1.15 to 3.20) 1.00 1.27 (1.01 to 1.60)
AOR* (95% CI) 1.00 1.67 (0.97 to 2.89) 1.00 1.18 (0.93 to 1.49)
Had a blood test for HIV, past year
Per cent 3.4 3.4 5.3 4.5
aAOR (95% CI) 1.00 1.16 (0.65 to 2.10) 1.00 0.93 (0.68 to 1.27)
AOR* (95% CI) 1.00 0.96 (0.50 to 1.84) 1.00 0.86 (0.63 to 1.18)
You or your partner used emergency contraception, past year
Per cent 2.3 2.0 1.5 2.5
aAOR (95% CI) 1.00 1.17 (0.52 to 2.61) 1.00 1.98 (1.23 to 3.19)
AOR* (95% CI) 1.00 1.01 (0.45 to 2.26) 1.00 1.71 (1.07 to 2.74)
Sought professional help regarding your sex life, past year
Per cent 6.4 16.6 5.7 12.5
aAOR (95% CI) 1.00 2.92 (1.98 to 4.30) 1.00 2.36 (1.83 to 3.04)
AOR* (95% CI) 1.00 2.89 (1.95 to 4.28) 1.00 2.36 (1.83 to 3.04)
All participants who have had at least one opposite-sex or same-sex partner, ever (denominators may vary across variables due to item
non-response).
Bold typeface highlights results where the confidence intervals exclude 1.0.
*Adjusted for age and 2+ partners without using a condom, past year.
†Participants aged 16–44 years.
aAOR, age-adjusted OR; GUM, genitourinary medicine.
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The differences in our findings might, in part, be due to
our survey methodology, which has been specifically
designed, with refinement over two decades, to collect
the most accurate data about sensitive sexual behaviours.
Other surveys in the UK have shown that mental health
symptoms are predictive of impaired sexual interest and
function in men and women,31 and a recent systematic
review also made this link.32 Studies in which partners
have been included confirm the poorer sexual function,
at least in men,33 who report fewer and weaker nocturnal
erections.34 The likely mechanisms behind these associa-
tions are complex. They include a cognitive bias where
depressed people experience lower satisfaction with sex
as well as other activities;35 higher risk of metabolic syn-
drome in depressed people with the cardiovascular
sequelae including sexual dysfunction;36 neuroendocrine
changes, and the effects of treatment.37 Up to two-thirds
of people treated with selective serotonin reuptake inhibi-
tors report sexual side effects,38 and such side effects are
often a reason for ceasing to take the medication.
Furthermore, antidepressants are often prescribed off-
license to treat premature ejaculation, and their inhibi-
tory sexual effects are well known.39 Our findings were
striking in the strength of associations seen for reduced
sexual function, and the high proportion reporting that
health conditions and medications had affected their sex
lives. This extended to specific symptoms, and we found
that more than three in five men, and more than two
in three women reporting treatment for depression
had also experienced sexual problems for more than
3 months in the past year. Our study is also unique in
including sexual health associations for a group reporting
depressive symptoms but no treatment. We observed
similar proportions of those reporting depressive symp-
toms but no treatment had experienced sexual problems,
which suggests that depression rather than its treatment
is more important in driving this association.
We know that individuals with sexual health problems
often do not seek help,40 41 and we also know that
attending specialist sexual health clinics can evoke a
range of psychological symptoms and concerns.42
However, there are few data available addressing the
important question about use of sexual health service in
people with depression, and our study adds substantially
to the literature in this respect.
Implications for policy and practice
Most depression is managed in primary care,2 and most
people with sexual function problems initially seek pro-
fessional help from their family doctor.43 In Britain,
many sexual health services are being moved into com-
munity and other primary care settings, which provides
an opportunity to align these areas of healthcare.44 45
We have considered two groups of individuals who may
present to primary care, those receiving treatment for
depression and those with depressive symptoms but not
recently treated, and we observed evidence of poor
sexual health in both. Depressed patients may therefore
derive benefit from holistic assessment of sexual health
and mental health,9 and by extension, appropriate and
successful treatment of depression might reduce sexual
risk-taking, and improve sexual function.
Our finding that men identifying as gay, and those
reporting same-sex partners, and women identifying as
bisexual and those reporting same-sex partners, were more
likely to report treatment for depression, is consistent with
the literature on lesbian, gay and bisexual (LGB)
people,46–49 who are at higher risk of mental ill health than
heterosexuals, and these data support the need for policies
that recognise coexisting health inequalities in LGB
groups.50 Similarly, we found a strong association between
reporting recent relationship breakup and treatment for
depression, highlighting the need to consider relationship
context in assessing patients’ mental health, and for pro-
active clinical management, which might include referral
to counselling organisations like ‘Relate UK’. Depression
was also more common in our study among another poten-
tially vulnerable group, women reporting use of emer-
gency contraception, which is an event that has been
associated with depression in poor urban women, while
the adverse outcome of unplanned pregnancy is a known
threat to mental health.51–55 In the UK, women may
readily obtain emergency contraception in pharmacies,
where the capacity to assess mental health needs is likely to
be limited by training and facilities to ensure confidential-
ity. Women accessing emergency contraception may, there-
fore, be in particular need of care in this respect, but
research and policy are lacking in this area.
Our study is also relevant to sexual health practitioners;
not only is the prevalence of mental health disorders
high among patients attending sexual health clinics, but
patients are more likely to reattend if staff recognise their
psychological problems.5 Although the British Medical
Association has called for greater importance to be given
to mental health, and advocates for a holistic approach to
care,56 the latest UK national guideline on consultations
requiring sexual history-taking fails to emphasise mental
health as an important comorbidity in patients requiring
sexual healthcare.57 There are already pilot schemes,
such as ‘Headspace’ in Australia, where mental and
sexual health services have established collaborative part-
nerships to ensure full sexual health assessments, advice,
treatment and referral as appropriate for clients.58 Our
data support such integrated approaches to managing
mental health and sexual health problems in primary
care as well as specialist settings. Interventional studies
might be required to understand whether such integra-
tive approaches are a benefit to patients.
Overall, this study gives family doctors, who may be
better placed to make links between services than other
healthcare professionals, much needed information for
understanding and improving the sexual health of
patients treated for depression, and provides evidence to
support the design of integrated approaches to man-
aging patients with overlapping sexual and mental
health needs.
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